Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochem (Q48596832)
Jump to navigation
Jump to search
scientific article published on 31 March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochem |
scientific article published on 31 March 2006 |
Statements
1 reference
Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochem (English)
1 reference
1 reference
Lee A Dawson
1 reference
Kathryn R Starr
1 reference
James D Storey
1 reference
Letizia Bettelini
1 reference
Fabrizio Bacchi
1 reference
Roberto Arban
1 reference
Alessandro Poffe
1 reference
Sergio Melotto
1 reference
James J Hagan
1 reference
Gary W Price
1 reference
31 March 2006
1 reference
1 reference
50
1 reference
8
1 reference
975-983
1 reference